Our Company
Our Company
About us
Our Team
Technology
Pipeline
Intranasal Foralumab
Secondary Progressive Multiple Sclerosis
Alzheimer’s Disease
Other Indications
Anti IL-6R (TZLS-501)
Milciclib (TZLS-201)
Investors, News & Media
News
Media
Publications
Investors
Contact
Select Page
KOL Event – 14 March 2022 at 11am ET
4th March 2022
https://myemail.constantcontac…
